Dr. Douglas A. Katsev, MD

Dr. Katsev practices at Santa Barbara Surgery Center in Santa Barbara, California.

Dr. Katsev's NPI, 1801906722, was assigned on August 30, 2006. Dr. Katsev graduated from Emory University School of Medicine in 1986. Dr. Katsev holds California license G65027.

Dr. Katsev's primary practice is Santa Barbara Surgery Center, at 3045 De La Vina St, Santa Barbara, CA 93105. The practice phone is (805) 569-3226.

Dr. Katsev's primary practice is Santa Barbara Surgery Center in Santa Barbara, California. Dr. Katsev is also affiliated with Santa Barbara Cottage Hospital. Dmand AI also links Dr. Katsev to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katsev practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Katsev's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Katsev is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Katsev's licenses on file in 2 states: California and Illinois.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Katsev treats.

CMS data shows 6,928 Medicare services from Dr. Katsev across 29 procedure codes in 2024, for 1,442 Medicare patients. Medicare paid $676,031 for them.

CMS counts 1,442 Medicare patients who saw Dr. Katsev in 2024. The largest group is 65 to 74, with 647 patients. 73% of them have high cholesterol, and 60% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Katsev's median patient age at 72, with 54% women.

In 2024, Dr. Katsev wrote 1,563 Medicare Part D claims for 502 patients. 55% of them were for generic drugs. CMS names the drug for 1,427 of them, across 30 drugs with 11 or more claims each, at $1,074,276 in total drug cost. In 2023, CMS named 1,266 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Katsev for performance year 2024, reported as part of a group. Dr. Katsev accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 553 procedures of cataract surgery by Dr. Katsev, more than 96% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Katsev, published from 2017 to 2025. The most frequent topics are Needles. Dr. Katsev's most frequent co-authors are Laura Marie Periman, MD, David J. Schanzlin, MD and William B. Trattler, MD.

CMS Open Payments shows 2,209 general payments to Dr. Katsev from 58 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 28% of the total. Shire North American Group Inc paid the most, $191,949.

Dmand AI lists 1 award for Dr. Katsev, most recently CMS Stage 1 EHR in 2013.

Dr. Katsev graduated from Emory University School of Medicine in 1986.

Dr. Katsev is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.